β-Galactosidase-dependent metabolic glycoengineering of tumor cells for imaging and immunotherapy.
Sign Up to like & getrecommendations! Published in 2022 at "Chemical communications"
DOI: 10.1039/d1cc06575k
Abstract: A β-Gal-dependent metabolic glycoengineering strategy was developed for tumor cell-selective surface glycan imaging with high efficacy. Combined with an antibody-recruiting strategy, targeted immunotherapy was achieved successfully based on this strategy. read more here.
Keywords: tumor cells; glycoengineering tumor; dependent metabolic; metabolic glycoengineering ... See more keywords